EyeCure
Latest round
- Series A
Last raised
- Nov 2016
Total raised
- Undisclosed
Investors
- 1
About EyeCure
Based in Wuxi, China and established in 2015, Eyecure is a bio-pharmaceutical company that focuses on developing and researching pharmaceutical biotechnology and clinical cytology, which can be utilised for curing age-related retina macular degeneration.
Who invested in EyeCure
1 investor across 1 round
See all investors in EyeCure
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 24, 2016
Amount
Undisclosed
Investors
Questions about EyeCure
Who invested in EyeCure?
EyeCure has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EyeCure raised?
EyeCure has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did EyeCure last raise money?
EyeCure's most recent round on record is a Series A, in Nov 2016.
What does EyeCure do?
Based in Wuxi, China and established in 2015, Eyecure is a bio-pharmaceutical company that focuses on developing and researching pharmaceutical biotechnology and clinical cytology, which can be utilised for curing age-related retina macular degeneration.
Where is EyeCure headquartered?
EyeCure is headquartered in Wuxi, China.
Which VCs invest in companies like EyeCure?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at EyeCure's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like EyeCure? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.